Brandon Aubrey, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 10 | 2022 | 2925 | 1.280 |
Why?
|
| Lymphoma | 10 | 2023 | 1898 | 0.990 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2024 | 3605 | 0.950 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2022 | 237 | 0.650 |
Why?
|
| Apoptosis | 8 | 2021 | 9492 | 0.450 |
Why?
|
| Genes, Essential | 1 | 2015 | 184 | 0.450 |
Why?
|
| Genes, Neoplasm | 1 | 2015 | 370 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2021 | 1135 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 1395 | 0.400 |
Why?
|
| Lentivirus | 1 | 2015 | 504 | 0.400 |
Why?
|
| Morpholines | 2 | 2024 | 582 | 0.330 |
Why?
|
| Histone Acetyltransferases | 2 | 2022 | 337 | 0.310 |
Why?
|
| Neoplasms | 5 | 2023 | 22019 | 0.260 |
Why?
|
| Phthalimides | 1 | 2024 | 34 | 0.230 |
Why?
|
| Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5630 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2021 | 1408 | 0.220 |
Why?
|
| Isoquinolines | 2 | 2021 | 353 | 0.200 |
Why?
|
| Indolizines | 1 | 2021 | 30 | 0.190 |
Why?
|
| Mutation | 5 | 2024 | 29877 | 0.190 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 302 | 0.190 |
Why?
|
| Azacitidine | 1 | 2022 | 334 | 0.180 |
Why?
|
| Ikaros Transcription Factor | 1 | 2022 | 231 | 0.180 |
Why?
|
| Sulfonamides | 2 | 2021 | 1972 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2019 | 2804 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 996 | 0.170 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 9528 | 0.160 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 2415 | 0.150 |
Why?
|
| Genes, p53 | 2 | 2021 | 714 | 0.150 |
Why?
|
| Transcription Factors | 5 | 2024 | 12106 | 0.150 |
Why?
|
| Benzenesulfonates | 1 | 2018 | 165 | 0.150 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 611 | 0.150 |
Why?
|
| Hydrazines | 1 | 2018 | 224 | 0.140 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2022 | 614 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 4491 | 0.130 |
Why?
|
| bcl-X Protein | 1 | 2017 | 413 | 0.130 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 98 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 21981 | 0.120 |
Why?
|
| Mice | 13 | 2023 | 81138 | 0.120 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 13621 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2022 | 951 | 0.120 |
Why?
|
| Azepines | 1 | 2016 | 329 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2022 | 2609 | 0.110 |
Why?
|
| Chromatin | 2 | 2022 | 2939 | 0.110 |
Why?
|
| Leukemia | 2 | 2019 | 1511 | 0.110 |
Why?
|
| Doxycycline | 1 | 2015 | 336 | 0.110 |
Why?
|
| Animals | 15 | 2023 | 167838 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 587 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14381 | 0.100 |
Why?
|
| Cell Survival | 3 | 2017 | 5796 | 0.090 |
Why?
|
| DNA Damage | 2 | 2021 | 2442 | 0.090 |
Why?
|
| Triazoles | 1 | 2016 | 905 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1627 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1175 | 0.090 |
Why?
|
| Gene Expression | 1 | 2022 | 7593 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3613 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5120 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2981 | 0.070 |
Why?
|
| Anemia | 1 | 2017 | 1509 | 0.070 |
Why?
|
| Humans | 16 | 2024 | 759255 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2017 | 23362 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2377 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3390 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8491 | 0.060 |
Why?
|
| Piperazines | 1 | 2016 | 2517 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2016 | 2996 | 0.060 |
Why?
|
| Cell Line | 2 | 2016 | 15636 | 0.060 |
Why?
|
| Base Sequence | 1 | 2015 | 12450 | 0.060 |
Why?
|
| Arrestins | 1 | 2023 | 73 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11908 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3584 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 13284 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16871 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9466 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 305 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3797 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9590 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2019 | 116 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2022 | 729 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7851 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2018 | 5427 | 0.040 |
Why?
|
| Erythroblasts | 1 | 2017 | 143 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1836 | 0.030 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 71 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2017 | 288 | 0.030 |
Why?
|
| Recombinases | 1 | 2016 | 66 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2017 | 246 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2628 | 0.030 |
Why?
|
| Hematopoietic System | 1 | 2016 | 109 | 0.030 |
Why?
|
| History, Ancient | 1 | 2016 | 211 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 1062 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 282 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 358 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1614 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 871 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 1002 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2017 | 682 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18110 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 963 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 1953 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10440 | 0.020 |
Why?
|
| Heterozygote | 1 | 2016 | 2796 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2017 | 2667 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3754 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 4084 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2582 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2896 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2918 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6532 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4716 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6897 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3449 | 0.010 |
Why?
|
| Stem Cells | 1 | 2016 | 3525 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18968 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9334 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 12940 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5793 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5214 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 5131 | 0.010 |
Why?
|
| Male | 2 | 2018 | 358719 | 0.010 |
Why?
|
| Female | 1 | 2016 | 390240 | 0.000 |
Why?
|